| 发明名称 |
CONTRAST AGENT |
| 摘要 |
According to one embodiment, a contrast agent includes a blood vessel contrast enhancement particles configured to enhance contrast of a blood vessel of an object and a diseased tissue contrast enhancement particles configured to enhance contrast of a diseased tissue of the object. The blood vessel contrast enhancement particles have a first particle size larger than a gap of vascular endothelial cells under an EPR effect. The diseased tissue contrast enhancement particles have a second particle size smaller than the gap. |
| 申请公布号 |
US2015037250(A1) |
申请公布日期 |
2015.02.05 |
| 申请号 |
US201414447841 |
申请日期 |
2014.07.31 |
| 申请人 |
Kabushiki Kaisha Toshiba ;Toshiba Medical Systems Corporation |
发明人 |
YAMAGATA Hitoshi |
| 分类号 |
A61K51/12;G01N33/50;A61K49/22;A61K49/00;A61K49/04;A61K49/18 |
主分类号 |
A61K51/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A contrast agent comprising a blood vessel contrast enhancement particle configured to enhance contrast of a blood vessel of an object and a diseased tissue contrast enhancement particle configured to enhance contrast of a diseased tissue of the object, the blood vessel contrast enhancement particle having a first particle size larger than a gap of vascular endothelial cells under an EPR effect, and the diseased tissue contrast enhancement particle having a second particle size smaller than the gap. |
| 地址 |
Minato-ku JP |
